Table 1 Clinical features of NSCLC patients: phenomic metadata
Patient characteristics at baseline | N° (%) |
|---|---|
Age | |
≤ 65 | 5 (45) |
> 65 | 6 (55) |
Sex | |
Male | 8 (73) |
Female | 3 (27) |
Histology | |
Adenocarcinoma | 1 (10) |
Squamous cell carcinoma | 10 (90) |
ECOG performance status | |
0–1 | 10 (90) |
> 1 | 1 (10) |
N° sites of metastasis | |
1 | 2 (18) |
> 1 | 9 (82) |
Brain metastases | |
Present | 1 (10) |
Absent | 10 (90) |
Treatment line | |
2 | 11 (100) |
> 2 | 0 (0) |
Previous platinum based chemotherapy | |
Yes | 9 (82) |
No | 2 (18) |
Response to nivolumab | |
Early progressors (EPs) | 4 (36) |
Long responder (LRs) | 7 (64) |